0000914190-13-000836.txt : 20131125 0000914190-13-000836.hdr.sgml : 20131125 20131125160405 ACCESSION NUMBER: 0000914190-13-000836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131121 FILED AS OF DATE: 20131125 DATE AS OF CHANGE: 20131125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin David CENTRAL INDEX KEY: 0001304318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 131241100 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-11-21 0001180145 Cardiovascular Systems Inc CSII 0001304318 Martin David 651 CAMPUS DRIVE ST. PAUL MN 55112 1 1 0 0 President and CEO Common Stock 2013-11-21 4 M 0 95900 8.83 A 449952 D Common Stock 2013-11-21 4 S 0 62303 32.92 D 387649 D Common Stock 2013-11-21 4 S 0 33597 33.19 D 354052 D Common Stock 1400 I By child Common Stock 1400 I By child Common Stock 1400 I By child Stock Option (right to buy) 8.83 2013-11-21 4 M 0 95900 0 D 2017-02-14 Common Stock 95900 100000 D Stock Option (right to buy) 7.90 2017-06-11 Common Stock 90580 90580 D Stock Option (right to buy) 12.15 2017-12-11 Common Stock 234395 234395 D Stock Option (right to buy) 8.75 2019-03-01 Common Stock 32350 32350 D The shares were sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.05 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.08 to $33.46 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully exercisable. /s/ Amanda Schmall as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney filed herewith. 2013-11-25 EX-24 2 martin.htm DAVID MARTIN POWER OF ATTORNEY

POWER OF ATTORNEY





 The undersigned hereby constitutes and appoints Laurence Betterley, James

 Flaherty, Jeffrey Points, Michael Killeen, Alexander Rosenstein, Amanda

 Schmall and Lori Cobb, or any one of them acting alone, the undersigned's true

 and lawful attorney-in-fact and agent with full power of substitution and

 resubstitution, for the undersigned and in the undersigned's name, place and

 stead, in any and all capacities, to sign any or all Forms 3, 4 or 5 relating

 to beneficial ownership of securities of Cardiovascular Systems, Inc. (the

 "Issuer"), to file the same, with all exhibits thereto and other documents in

 connection therewith, with the Securities and Exchange Commission and to

 deliver a copy of the same to the Issuer, granting unto said attorney-in-fact

 and agent full power and authority to do and perform each and every act and

 thing requisite and necessary to be done in and about the premises, as fully

 to all intents and purposes as the undersigned might or could do in person,

 hereby ratifying and confirming all said attorney-in-fact and agent, or his

 substitute or substitutes, may lawfully do or cause to be done by virtue

 thereof.  The undersigned acknowledges that the foregoing attorney-in-fact, in

 serving in such capacity at the request of the undersigned, is not assuming

 any of the undersigned's responsibilities to comply with Section 16 of the

 Securities Exchange Act of 1934.





 This Power of Attorney shall remain in effect until such time as the

 undersigned is no longer subject to the provisions of Section 16 of the

 Securities Exchange Act of 1934 with respect to securities of the Issuer.





 The undersigned hereby indemnifies the attorneys-in-fact for all losses

 and costs the attorneys-in-fact may incur in connection with or arising from

 the attorneys-in-fact's execution of their authorities granted hereunder.





 IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to

 be executed as of this 13th day of November, 2013.









       /s/ David L. Martin

       David L. Martin